Table 3.
Adjusted odds ratios of hyperuricemia among participants associated with serum 25(OH)D.
| Serum 25(OH)D levels (nmol/L) | p for trend | ||||||
|---|---|---|---|---|---|---|---|
| Q1 (<41.8) | Q2 (41.8–55.4) | Q3 (55.5–66.4) | Q4 (66.5–80.4) | Q5 (≥80.5) | |||
| (n = 1,583) | (n = 1,582) | (n = 1,579) | (n = 1,593) | (n = 1,590) | |||
| Male (n = 7,927) | Model 1a | Reference | 0.80 (0.68, 0.95) | 0.94 (0.79, 1.11) | 0.68 (0.57, 0.82) | 0.72 (0.60, 0.86) | <0.0001 |
| Model 2b | Reference | 0.79 (0.67, 0.94) | 0.93 (0.78, 1.10) | 0.67 (0.56, 0.80) | 0.71 (0.59, 0.86) | 0.0001 | |
| Model 3c | Reference | 0.78 (0.65, 0.93) | 0.97 (0.81, 1.16) | 0.72 (0.60, 0.88) | 0.82 (0.68, 1.00) | 0.0479 | |
| Q1 (<39.8) | Q2 (39.8–55.3) | Q3 (55.4–69.3) | Q4 (69.4–87.2) | Q5 (≥87.3) | |||
| (n = 1,556) | (n = 1,561) | (n =1,549) | (n = 1,562) | (n = 1,568) | |||
| Female (n = 7,796) | Model 1a | Reference | 0.85 (0.71, 1.01) | 0.72 (0.60, 0.86) | 0.71 (0.59, 0.85) | 0.67 (0.56, 0.80) | <0.0001 |
| Model 2b | Reference | 0.84 (0.71, 1.00) | 0.72 (0.60, 0.86) | 0.72 (0.60, 0.86) | 0.69 (0.57, 0.83) | <0.0001 | |
| Model 3c | Reference | 0.90 (0.75, 1.09) | 0.80 (0.66, 0.97) | 0.83 (0.68, 1.01) | 0.85 (0.69, 1.05) | 0.0977 | |
a
Adjusted for age, race/ethnicity;
b
adjusted for age, race/ethnicity, smoking status, drinking status, hypertension status and diabetes status;
c
adjusted for age, race/ethnicity, smoking status, drinking status, hypertension status, diabetes status, creatinine, STC, glucose, BMI, HDL-C, STG, serum calcium, magnesium intake, zinc intake, fiber intake.